← Back to Clinical Trials
Recruiting NCT06588582

NCT06588582 Perceptual Influences From Smoking Cannabis: an Experimental Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06588582
Status Recruiting
Phase
Sponsor University of Colorado, Boulder
Condition Cannabis Use
Study Type INTERVENTIONAL
Enrollment 166 participants
Start Date 2025-02-17
Primary Completion 2029-07-01

Eligibility & Interventions

Sex All sexes
Min Age 21 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Water Temperature Variation - WWWater Temperature Variation - CW

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 166 participants in total. It began in 2025-02-17 with a primary completion date of 2029-07-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of the study is to better understand the effects of cannabis in relation to mental and physical states including its relationship with mood, cognition, perception including the experience of temperature and pain, and heart rate. We expect that participants will be in this research study for approximately one week. The total amount of time that participants will spend completing study tasks will be about 2.5 hours across two separate in-person visits.

Eligibility Criteria

Inclusion Criteria: * 21-65 years of age * Endorsement of at least some use of cannabis for coping purposes (\>1 on CMMQ) * Regularly use flower cannabis products (i.e., ≥1x/week in the last 6 months) * Proficient in English language * At least occasional use of CBD+THC or CBD-dominant products (e.g., ≥1x/month) Exclusion Criteria: * Diagnosis or use of medications for substance use or psychotic disorders * Report of other drug use (cocaine, opiates, methamphetamine) in the past 90 days or fail urine screen for any of these drugs * Females cannot be pregnant or trying to become pregnant or nursing mothers * Not able to provide informed consent

Contact & Investigator

Central Contact

Carillon Skrzynski, PhD

✉ carillon.skrzynski@colorado.edu

📞 (734)788-2961

Frequently Asked Questions

Who can join the NCT06588582 clinical trial?

This trial is open to participants of all sexes, aged 21 Years or older, up to 65 Years, studying Cannabis Use. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06588582 currently recruiting?

Yes, NCT06588582 is actively recruiting participants. Contact the research team at carillon.skrzynski@colorado.edu for enrollment information.

Where is the NCT06588582 trial being conducted?

This trial is being conducted at Boulder, United States.

Who is sponsoring the NCT06588582 clinical trial?

NCT06588582 is sponsored by University of Colorado, Boulder. The trial plans to enroll 166 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology